|
More site info...
Anti-Virals | Forum profile
|
|
Forum profile page for Anti-Virals on http://www.flutrackers.com.
This report page is the aggregated overview from a single forum: Anti-Virals , located on the Message Board at http://www.flutrackers.com.
This forum profile page summarizes the general forum statistics such as: Users Activity, Forum Activity, and Top Authors, which are reported in either a table or graph below for a given reporting time period.
Additional forum profile information for "Anti-Virals " on the Message Board at http://www.flutrackers.com is also shown in the following ways:
1) Latest Active Threads
2) Hot Threads for Last Week
Warning: These statistics are generated using 'best efforts' and can experience delays and reporting errors at times. Please note that such statistics do not constitute a forum's popularity and/or exact posting volumes at any given reporting period.
|
|
|
|
|
Posting activity on Anti-Virals :
|
|
Week
|
Month
|
3 Months
|
|
Threads:
|
10
|
20
|
44
|
|
Post:
|
21
|
34
|
73
|
|
|
Anti-Virals Posting activity graph:
|
Top authors during last week:
user's latest post:
BMJ. Neuraminidase inhibitors...
Published (2009-12-12 01:01:00)
BMJ. 2009 Dec 8;339:b5106. doi: 10.1136/bmj.b5106. Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis. Jefferson T, Jones M, Doshi P, Del Mar C. - Acute Respiratory Infections Group, Cochrane Collaboration, Rome, Italy. Comment in: * BMJ. 2009;339:b5351. * BMJ. 2009;339:b5364. OBJECTIVES: To update a 2005 Cochrane review that assessed the effects of neuraminidase inhibitors in...
user's latest post:
BMJ. Neuraminidase inhibitors...
Published (2009-12-12 01:01:00)
BMJ. 2009 Dec 8;339:b5106. doi: 10.1136/bmj.b5106. Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis. Jefferson T, Jones M, Doshi P, Del Mar C. - Acute Respiratory Infections Group, Cochrane Collaboration, Rome, Italy. Comment in: * BMJ. 2009;339:b5351. * BMJ. 2009;339:b5364. OBJECTIVES: To update a 2005 Cochrane review that assessed the effects of neuraminidase inhibitors in...
user's latest post:
BMJ. Neuraminidase inhibitors...
Published (2009-12-09 03:33:00)
> The drugs are effective postexposure against laboratory > confirmed influenza, but this is a small component of > influenza-like illness, so for this outcome neuraminidase > inhibitors are not effective I don't understand this. are effective ... but ... are not effective
user's latest post:
BMJ. Neuraminidase inhibitors...
Published (2009-12-09 03:33:00)
> The drugs are effective postexposure against laboratory > confirmed influenza, but this is a small component of > influenza-like illness, so for this outcome neuraminidase > inhibitors are not effective I don't understand this. are effective ... but ... are not effective
user's latest post:
Pre- and postexposure use of...
Published (2009-12-04 07:16:00)
J Infect Dis. 2009 Dec 15;200(12):1870-3. Pre- and postexposure use of human monoclonal antibody against H5N1 and H1N1 influenza virus in mice: viable alternative to oseltamivir. Koudstaal W, Koldijk MH, Brakenhoff JP, Cornelissen LA, Weverling GJ, Friesen RH, Goudsmit J. Crucell Holland BV, 2333 CN Leiden, the Netherlands. wouter.koudstaal@crucell.com New strategies to prevent and treat influenza virus infections are urgently needed. A...
user's latest post:
Euro Surveill. Prolonged...
Published (2009-12-10 12:34:00)
Quote: .....it seems plausible that prolonged viral shedding in our patients was more likely to be associated with the rather severe clinical course in both cases. I would assume this means that HCW cannot assume that the virus has cleared after 7-10 days in their severe patients. How many severely ill patients are discharged before this longer clearance period has been finished? . .
user's latest post:
Cases J. Influenza A (H1N1) in...
Published (2009-12-11 23:50:00)
Influenza A (H1N1) in Rome, Italy in family: three case reports Francesco Lisena , Licia Bordi , Fabrizio Carletti , Concetta Castilletti , Federica Ferraro , Eleonora Lalle , Simone Lanini , Luca Enrico Ruscitti , and Francesco Maria Fusco Istituto Nazionale per le Malattie Infettive IRCCS Lazzaro Spallanzani - Roma Via Portuense, 292 - 00149 Rome, Italy Cases Journal 2009, 2 : 9123doi:10.1186/1757-1626-2-9123 The electronic version of this...
|
|
|
|
Latest active threads on Anti-Virals ::
Started 4 days, 23 hours ago (2009-12-10 12:34:00)
by AlaskaDenise
Quote:
.....it seems plausible that prolonged viral shedding in our patients was more likely to be associated with the rather severe clinical course in both cases.
I would assume this means that HCW cannot assume that the virus has cleared after 7-10 days in their severe patients. How many severely ill patients are discharged before this ...
Started 3 days, 11 hours ago (2009-12-12 01:01:00)
by ironorehopper's Avatar
BMJ. 2009 Dec 8;339:b5106. doi: 10.1136/bmj.b5106.
Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis.
Jefferson T, Jones M, Doshi P, Del Mar C. - Acute Respiratory Infections Group, Cochrane Collaboration, Rome, Italy.
Comment in:
* BMJ. 2009;339:b5351.
* BMJ. 2009;339:b5364.
OBJECTIVES:
To update...
Started 6 days, 10 hours ago (2009-12-09 01:45:00)
by ironorehopper's Avatar
Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis -- Jefferson et al. 339: b5106 (BMJ, abstract, edited)
Published 8 December 2009, doi:10.1136/bmj.b5106
Cite this as: BMJ 2009;339:b5106
Research
Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-...
Started 6 days, 10 hours ago (2009-12-09 02:05:00)
by ironorehopper's Avatar
Complications: tracking down the data on oseltamivir -- Cohen 339: b5387 (BMJ, extract, edited)
Published 8 December 2009, doi:10.1136/bmj.b5387
Cite this as: BMJ 2009;339:b5387
Feature
Complications: tracking down the data on oseltamivir
Deborah Cohen, BMJ
dcohen@bmj.com
Editorial, doi:10.1136/bmj.b5351
Research, doi:10.1136/bmj.b5106
Analysis, doi:10.1136/bmj....
Started 6 days, 10 hours ago (2009-12-09 01:57:00)
by ironorehopper's Avatar
Why don't we have all the evidence on oseltamivir? -- Godlee and Clarke 339: b5351 (BMJ, extract, edited)
[Source Full Free Document: LINK . EDITED.]
Published 8 December 2009, doi:10.1136/bmj.b5351
Cite this as: BMJ 2009;339:b5351
Editorials
Why dont we have all the evidence on oseltamivir?
The full data from drug trials must be available for scrutiny by the ...
Started 6 days, 10 hours ago (2009-12-09 01:52:00)
by ironorehopper's Avatar
What can we learn from observational studies of oseltamivir to treat influenza in healthy adults? -- Freemantle and Calvert 339: b5248 (BMJ, extract, edited)
[Source Full Free Document: LINK . EDITED.]
Published 8 December 2009, doi:10.1136/bmj.b5248
Cite this as: BMJ 2009;339:b5248
Analysis
What can we learn from observational studies of oseltamivir to treat influenza in ...
Started 1 week, 3 days ago (2009-12-05 02:16:00)
by ironorehopper's Avatar
Drugs. 2009;69(18):2523-31. doi: 10.2165/11531450-000000000-00000.
Oseltamivir resistance and the H274Y neuraminidase mutation in seasonal, pandemic and highly pathogenic influenza viruses.
Hurt AC, Holien JK, Parker MW, Barr IG. - WHO Collaborating Centre for Reference and Research on Influenza, Melbourne, Victoria, Australia. aeron.hurt@influenzacentre.org
Along with influenza ...
|
|
Hot threads for last week on Anti-Virals ::
Started 6 days, 10 hours ago (2009-12-09 01:45:00)
by ironorehopper's Avatar
Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis -- Jefferson et al. 339: b5106 (BMJ, abstract, edited)
Published 8 December 2009, doi:10.1136/bmj.b5106
Cite this as: BMJ 2009;339:b5106
Research
Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-...
Started 4 days, 23 hours ago (2009-12-10 12:34:00)
by AlaskaDenise
Quote:
.....it seems plausible that prolonged viral shedding in our patients was more likely to be associated with the rather severe clinical course in both cases.
I would assume this means that HCW cannot assume that the virus has cleared after 7-10 days in their severe patients. How many severely ill patients are discharged before this ...
Started 6 days, 10 hours ago (2009-12-09 02:05:00)
by ironorehopper's Avatar
Complications: tracking down the data on oseltamivir -- Cohen 339: b5387 (BMJ, extract, edited)
Published 8 December 2009, doi:10.1136/bmj.b5387
Cite this as: BMJ 2009;339:b5387
Feature
Complications: tracking down the data on oseltamivir
Deborah Cohen, BMJ
dcohen@bmj.com
Editorial, doi:10.1136/bmj.b5351
Research, doi:10.1136/bmj.b5106
Analysis, doi:10.1136/bmj....
Started 6 days, 10 hours ago (2009-12-09 01:52:00)
by ironorehopper's Avatar
What can we learn from observational studies of oseltamivir to treat influenza in healthy adults? -- Freemantle and Calvert 339: b5248 (BMJ, extract, edited)
[Source Full Free Document: LINK . EDITED.]
Published 8 December 2009, doi:10.1136/bmj.b5248
Cite this as: BMJ 2009;339:b5248
Analysis
What can we learn from observational studies of oseltamivir to treat influenza in ...
Started 6 days, 10 hours ago (2009-12-09 01:57:00)
by ironorehopper's Avatar
Why don't we have all the evidence on oseltamivir? -- Godlee and Clarke 339: b5351 (BMJ, extract, edited)
[Source Full Free Document: LINK . EDITED.]
Published 8 December 2009, doi:10.1136/bmj.b5351
Cite this as: BMJ 2009;339:b5351
Editorials
Why dont we have all the evidence on oseltamivir?
The full data from drug trials must be available for scrutiny by the ...
Started 3 days, 11 hours ago (2009-12-12 01:01:00)
by ironorehopper's Avatar
BMJ. 2009 Dec 8;339:b5106. doi: 10.1136/bmj.b5106.
Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis.
Jefferson T, Jones M, Doshi P, Del Mar C. - Acute Respiratory Infections Group, Cochrane Collaboration, Rome, Italy.
Comment in:
* BMJ. 2009;339:b5351.
* BMJ. 2009;339:b5364.
OBJECTIVES:
To update...
|
|
Size: 719 bytes
